Form 8-K - Current report:
SEC Accession No. 0001193125-26-282989
Filing Date
2026-06-25
Accepted
2026-06-25 17:00:13
Documents
11
Period of Report
2026-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d143621d8k.htm   iXBRL 8-K 27437
  Complete submission text file 0001193125-26-282989.txt   146113

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coya-20260625.xsd EX-101.SCH 3205
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20260625_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20260625_pre.xml EX-101.PRE 11724
14 EXTRACTED XBRL INSTANCE DOCUMENT d143621d8k_htm.xml XML 3768
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 261122834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)